跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IN-015
首页
药物
IN-015
IN-015
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
IL-15 MUTANT-Fc/IL-15R ALPHA SUBUNIT-Fc HETERODIMER AND USE THEREOF
US 20250345397 A1
申请人: YIFAN PHARMACEUTICAL SHANGHAI CO LTD
优先权: 2022
CN
EP
US
WO
5 件公开
Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease
US 8956611 B2
申请人: PONCE JR RAFAEL A
优先权: 2008
US
2 件公开
Novel signal transduction molecules
US 2002086300 A1
申请人: ADLER JON ELLIOT
优先权: 2001
US
Kit of parts for nail make-up with mirror effect
EP 1462085 A1
申请人: OREAL
优先权: 2003
EP
Method for fermenting Streptomyces tauricus strain for producing anticancer active substances and method for extracting secondary metabolites of Streptomyces tauricus strain
CN 109082390 A
申请人: UNIV NORTHWEST MINZU
优先权: 2018
CN
Combination therapies for treating cancer
US 11931352 B2
申请人: UNIV VIRGINIA PATENT FOUNDATION
优先权: 2019
US
Method for reducing content of genotoxic impurities of indobufen
CN 114516827 A
申请人: HANGZHOU ZHONGMEI EAST CHINA PHARMACY LTD COMPANY
优先权: 2020
CN
六株广谱中和SARS-CoV-2的中和抗体及其应用
CN 116410307 B
申请人: 清华大学
优先权: 2021
CN
MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF
WO 2024107729 A3
申请人: JANSSEN PHARMACEUTICALS INC
优先权: 2022
WO
Bacillus velezensis Yian-sdu-015 and application thereof as well as reducing polysaccharide and preparation method thereof
CN 116515692 A
申请人: DEZHOU MAIKE BIOTECHNOLOGY CO LTD
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈